{"changes":[{"companyHref":"/c/dittobio-com","date":"2026-09-24","documentUrl":"https://www.ycombinator.com/companies/ditto-biosciences","domain":"dittobio.com","fact":"provenance:existence","name":"Ditto Biosciences","new":{"publisher":"Y Combinator","status":"sourced","url":"https://www.ycombinator.com/companies/ditto-biosciences"},"old":{"publisher":"dittobio.com","status":"self-reported","url":"https://dittobio.com"},"publisher":"Y Combinator","reason":null,"retrievedAt":"2026-09-17","slug":"dittobio-com","status":"sourced","url":"https://whoraisedwhat.com/c/dittobio-com"}],"country":"US","description":"AI platform that mines parasite proteins for novel autoimmune-disease drug candidates. Built around partnered or wholly-owned clinical pipeline targeting RA, IBD, MS, T1D, and psoriasis. Y Combinator-backed; pitches an untapped natural drug source.","domain":"dittobio.com","employees":null,"founded":2025,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"healthtech","investors":[],"lat":null,"lng":null,"location":null,"name":"Ditto Biosciences","rounds":[{"amountQuarantined":false,"amountUsd":1000000,"currency":"USD","date":"2026-01-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"yc","retrievedAt":"2026-09-25","status":"attributed","url":null},"status":"attributed","type":"seed","url":null}],"slug":"dittobio-com","sources":[{"fact":"round","publisher":"yc","retrievedAt":"2026-09-25","status":"attributed","url":null},{"fact":"existence","publisher":"Y Combinator","retrievedAt":"2026-09-17","status":"sourced","url":"https://www.ycombinator.com/companies/ditto-biosciences"},{"fact":"description","publisher":"dittobio.com","retrievedAt":"2026-09-25","status":"self-reported","url":"https://dittobio.com"}],"stage":"seed","techStack":["Vercel","HeroUI","React","posthog-js","@sentry/browser","Next.js"],"totalRaisedUsd":1000000,"updatedAt":"2026-09-25"}